Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Bevacizumab for Vitreous Hemorrhage
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
- Status
- COMPLETED
- Phase
- PHASE3
RAD001 Plus Bevacizumab in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow Blasts
- Status
- TERMINATED
- Phase
- PHASE2